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Background:  Influenza can trigger acute coronary syndromes and influenza vaccine can prevent such events. American College of Cardiology and 
American Heart Association recommend influenza vaccine for all the patients with cardiac diseases in absence of contraindications. However, the 
vaccination rate still remains around <60%. We conducted a survey to evaluate the cardiologists’ perspectives on prevention of influenza.
Methods:  We conducted a randomized nationwide mail survey of cardiologists. We designed a 15- items questionnaire focusing on cardiologists’ 
knowledge, practice, and attitude on influenza vaccination in cardiac patients. A random sample of 3,005 cardiologists was selected from American 
Medical Association members list. The questionnaire was sent to cardiologists via mail. A subsequent reminder was sent to subjects after 4 weeks 
with a follow up for non-responders. 
Results:  We received about 483 responses by fax and mail. About 90.7% of cardiologists regularly recommended annual influenza vaccine. Only 
50.3% maintained a vaccine stock at their place of practice. Only 66.7% believed that influenza can trigger heart attacks and 88.7% believed that 
all the patients with cardiovascular should be vaccinated against influenza. Only 38.4% believed that vaccine can provide enough protection in 
the elderly. Sixty five percent were aware of ACC and AHA recommendations and 53.7% stated that this has led to their increased endorsement of 
vaccination. A minority (30.3%) have tried post-exposure oseltamivir therapy. Primary reasons for not recommending the vaccine included: A belief 
that vaccination is the primary care physician’s job (75.7 %), not having a vaccine stock (38.7%) at the office, lack of time (15.1%). Only 81.7% of 
the cardiologists had received the vaccine themselves.
Conclusions:  While influenza vaccine is recommended for all cardiac patients, its use is considerably lower that optimum. More aggressive efforts 
with focus on all physician groups and patients are needed to increase vaccination rate.
